Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China.
Acta Obstet Gynecol Scand. 2021 Jun;100(6):1116-1123. doi: 10.1111/aogs.14058. Epub 2021 Jan 12.
Frozen embryo transfer is associated with a higher rate of live birth and a lower risk for ovarian hyperstimulation syndrome in women with polycystic ovary syndrome (PCOS) compared with fresh embryo transfer. The aim of this study is to assess the optimal endometrial preparation protocol for women with PCOS undergoing frozen embryo transfer.
We conducted a historical cohort analysis of 1720 women with PCOS who underwent the "freeze-all" strategy between August 2014 and August 2017 because of their high risk for ovarian hyperstimulation syndrome. Three endometrial preparation protocols were used: natural cycle (NC; n = 191), which relies on the dominant follicle to secrete estrogen that then promotes endometrial growth; ovarian stimulation (OS; n = 96), which induces follicle growth using low doses of human menopausal gonadotropin; and hormone replacement (HRT; n = 1433), which uses exogenous estradiol to promote endometrial growth. The primary outcome was live birth.
For women who received a single embryo transfer, the live birth rates for the NC, OS, and HRT groups were 62.4%, 65.0%, and 52.2%, respectively. The live birth rate in the HRT group was significantly lower than that seen in the OS and NC groups (P = .009). The clinical pregnancy rates of the three groups were 72.3%, 73.8%, and 64.9%, respectively; this difference did not reach statistical significance (P = .071).
The rate of live birth with the NC and OS regimens was higher than with the HRT protocol in women with PCOS who undergo single-blastocyst frozen embryo transfer.
与新鲜胚胎移植相比,冷冻胚胎移植可提高多囊卵巢综合征(PCOS)女性的活产率并降低卵巢过度刺激综合征的风险。本研究旨在评估 PCOS 女性行冷冻胚胎移植时的最佳内膜准备方案。
我们对 2014 年 8 月至 2017 年 8 月期间因卵巢过度刺激综合征风险高而采用“全冻”策略的 1720 例 PCOS 患者进行了历史队列分析。采用三种内膜准备方案:自然周期(NC;n=191),依靠优势卵泡分泌雌激素,进而促进内膜生长;卵巢刺激(OS;n=96),采用小剂量人绝经期促性腺激素诱导卵泡生长;以及激素替代(HRT;n=1433),采用外源性雌二醇促进内膜生长。主要结局为活产。
对于接受单个胚胎移植的患者,NC、OS 和 HRT 组的活产率分别为 62.4%、65.0%和 52.2%。HRT 组的活产率明显低于 OS 组和 NC 组(P=0.009)。三组的临床妊娠率分别为 72.3%、73.8%和 64.9%;差异无统计学意义(P=0.071)。
在接受单个囊胚冷冻胚胎移植的 PCOS 女性中,NC 和 OS 方案的活产率高于 HRT 方案。